MYCN and neoplasm: To determine the independent immune profiles of 11q‐deleted and MYCN‐amplified tumor subtypes, patients were divided into three subgroups: (a) 11q‐deleted (n = 18), (b) MYCN‐amplified (n = 27), and (c) 11q normal without MNA (n = 5), here referred as others.